-
Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
(PAR-23-151)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institute on Drug Abuse
Application Receipt Date(s): August 9, 2023
-
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
(PAR-23-183)
National Library of Medicine
Application Receipt Date(s): February 26, 2026
-
Alcohol Health Services Research (R01 Clinical Trial Optional)
(PAR-23-185)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): July 18, 2023
-
Alcohol Health Services Research (R34 Clinical Trial Optional)
(PAR-23-186)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): July 18, 2023
-
Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
(PAR-23-187)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): July 18, 2023
-
Alcohol Treatment and Recovery Research (R34 Clinical Trial required)
(PAR-23-188)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): July 18, 2023
-
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
(PAR-23-193)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): October 3, 2023, April 3, 2024, October 3, 2024, April 3, 2025, October 3, 2025, April 3, 2026
-
Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
(RFA-AG-24-021)
National Institute on Aging
Application Receipt Date(s): October 23, 2023
-
Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)
(RFA-AG-24-022)
National Institute on Aging
Application Receipt Date(s): October 23, 2023
-
Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
(RFA-AG-24-023)
National Institute on Aging
Application Receipt Date(s): October 23, 2023
-
Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)?
(RFA-AG-24-036)
National Institute on Aging
Application Receipt Date(s): October 23, 2023
-
Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)
(RFA-AG-24-038)
National Institute on Aging
Application Receipt Date(s): October 23, 2023
-
Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed)
(RFA-AI-23-029)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed)
(RFA-AI-23-032)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): August 25, 2023
-
Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional)
(RFA-DA-24-016)
National Institute on Drug Abuse
Application Receipt Date(s): November 02, 2023
-
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required)
(RFA-DA-24-024)
National Institute on Drug Abuse
Application Receipt Date(s): November 2, 2023
-
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)
(RFA-DA-24-028)
National Institute on Drug Abuse
Application Receipt Date(s): November 2, 2023
-
Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required)
(RFA-DA-24-029)
National Institute on Drug Abuse
Application Receipt Date(s): November 2, 2023
-
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed)
(RFA-DK-23-009)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): October 26, 2023
-
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed)
(RFA-DK-23-010)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): October 26, 2023
-
Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)
(RFA-HD-24-005)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): August 7, 2023
-
Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
(RFA-NS-23-027)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
-
Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed)
(RFA-NS-24-003)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): July 28, 2023
-
Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
(RFA-NS-24-010)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): September 08, 2023